Skip to content
Recall Observatory FDA recall evidence

Drug product

ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7129-61

D-0366-2025

April 14, 2025

Class II

Product summary

Firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Event
Event 96679
Status
Ongoing
Classification
Class II
Quantity
133 cartons
Official record key
drug-enforcement:D-0366-2025

Official wording

Reason: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Code information: Lot#: N02114, Exp 12/31/2025

Distribution pattern: Nationwide USA

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso-Desmethyl Chlorpromazine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP deviations